Ending Drug Trafficking in Our Communities Act
- Bill Number
- H.R. 2194
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Crime and Law Enforcement
- Status
- Introduced
- Latest Action
- 2025-03-18: Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2025-03-31T16:22:30Z
AI-Generated Summary
Purpose
The "Ending Drug Trafficking in Our Communities Act" (H.R. 2194) aims to reauthorize and improve the High Intensity Drug Trafficking Areas (HIDTA) Program, which designates specific regions in the U.S. for coordinated efforts to combat drug trafficking. The bill extends funding for the program and introduces requirements to identify and implement "promising practices" (effective strategies not yet fully proven but showing potential) to make anti-drug efforts more efficient, particularly in addressing overdoses, crime coordination, and substance use prevention.
Key Provisions
- Funding Reauthorization: Allocates $400,000,000 annually for the HIDTA Program from fiscal year 2026 through 2031.
- Promising Practices Integration (effective starting fiscal year 2026):
- The Director of the Office of National Drug Control Policy (ONDCP) must review identified promising practices to assess their potential to improve HIDTA operations.
- Focus areas include:
- Identifying and investigating groups trafficking illegal drugs linked to overdoses in HIDTA regions.
- Enhancing information sharing and coordination among federal, state, territorial, Tribal, and local agencies to respond to drug-related crimes and the criminal use of firearms.
- Implementing and evaluating evidence-based (research-supported) prevention programs, strategies, and initiatives for substance use disorders.
- For practices deemed effective, the Director must develop them for HIDTA use and distribute them to all HIDTA programs.
Significant Changes to Existing Law
- Amends Section 707(p) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1706(p)) by adding specific annual funding levels for 2026–2031, extending beyond previous authorizations.
- Amends Section 707(q) (21 U.S.C. 1706(q)) by adding a new subsection on promising practices, requiring the ONDCP Director to systematically review, develop, and promulgate these strategies starting in 2026. This introduces a proactive, ongoing process for innovation in HIDTA activities, which was not previously mandated.
Potential Impacts
- Government Agencies: Strengthens the ONDCP's role in overseeing HIDTAs, potentially increasing coordination and resource efficiency among federal, state, local, and Tribal law enforcement. This could lead to more targeted investigations and prevention efforts, reducing administrative silos.
- Citizens: Residents in HIDTA-designated areas (high-drug-trafficking regions) may see reduced drug-related overdoses, crime, and firearm violence through better prevention and response strategies. Broader communities could benefit from evidence-based substance use disorder programs that emphasize prevention over punishment.
- International Relations: Minimal direct impact, as the program focuses on domestic trafficking, though improved U.S. interdiction could indirectly affect cross-border drug flows from international sources.
Main Stakeholders Affected
- Federal Government: ONDCP and related agencies (e.g., Department of Justice, Homeland Security) responsible for funding and implementing HIDTA activities.
- State, Local, Territorial, and Tribal Governments: Law enforcement and public health entities in HIDTA regions, who will receive new tools and coordination support.
- Communities and Citizens: Individuals in drug-trafficking hotspots, including those at risk of overdoses or substance use disorders, who stand to gain from enhanced prevention and enforcement.
- Law Enforcement and Prevention Organizations: Groups involved in drug investigations, information sharing, and community programs, which must adopt the new promising practices.
Notable Legal, Constitutional, or Political Implications
- Legal: Builds on existing federal authority under the 1998 Act without expanding it significantly; the focus on evidence-based practices ensures compliance with administrative law requirements for effective program management. No new enforcement powers are granted, avoiding potential Fourth Amendment concerns related to searches or surveillance.
- Constitutional: Aligns with Congress's spending power (Article I, Section 8) to fund anti-drug initiatives; emphasizes intergovernmental cooperation, respecting federalism by involving state and Tribal partners without overriding their authority.
- Political: Introduced with bipartisan sponsorship (Representatives Harder, D-CA, and Moran, R-KS), signaling potential for broad support in addressing the opioid and fentanyl crises. It prioritizes prevention alongside enforcement, reflecting a shift toward comprehensive drug policy that could influence future appropriations debates.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (2)
Rep. Moran, Nathaniel [R-TX-1], Rep. Fitzpatrick, Brian K. [R-PA-1]
Recent Actions
- 2025-03-18: Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-03-18: Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-03-18: Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-03-18: Introduced in House
- 2025-03-18: Introduced in House
Bill Versions
- Ending Drug Trafficking in Our Communities Act — issued 2025-03-18 — PDF (3 pages)